Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Another NDA?

I have no problem with an NDA and not knowing financial details of settlements as long as the numbers show up in the Q reports. I don't care.

My beef is that investors have been told that license fees are being collected in the form of a one time lump sum payment. IF the license fees are being collected in another way other than one time fees, I feel that PTSC has a responsibility to share only that information to investors. Don't tell us which companies are making settlements this way but tell us that licensing fees are being collected from some companies with more than one payment. Why would just that much information violate an NDA. We wont know which companies are paying this way. How would the SP respond if investors knew that some companies could be making multiple payments and PTSC would have recurring revenue.

All the best,

Steve

Share
New Message
Please login to post a reply